ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 190 filers reported holding ABCELLERA BIOLOGICS INC in Q3 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $712,500 | -14.4% | 94,496 | +12.3% | 0.02% | -14.8% |
| Q3 2022 | $832,000 | -8.5% | 84,143 | -6.4% | 0.03% | +3.8% |
| Q2 2022 | $909,000 | +8.2% | 89,895 | +4.4% | 0.03% | +52.9% |
| Q1 2022 | $840,000 | -31.1% | 86,123 | +1.2% | 0.02% | -29.2% |
| Q4 2021 | $1,220,000 | -38.4% | 85,105 | -16.4% | 0.02% | -35.1% |
| Q3 2021 | $1,979,000 | +16.3% | 101,764 | +27.2% | 0.04% | +32.1% |
| Q2 2021 | $1,702,000 | -12.2% | 79,972 | +10.1% | 0.03% | -17.6% |
| Q1 2021 | $1,938,000 | – | 72,624 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $37,320,000 | 92.58% |
| Gruss & Co., LLC | 308,570 | $3,052,000 | 26.27% |
| Founders Fund Growth Management, LLC | 407,017 | $4,025,000 | 11.55% |
| Belmont Capital, LLC | 510,000 | $5,044,000 | 5.95% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $40,599,000 | 5.05% |
| GUARDIAN CAPITAL ADVISORS LP | 3,736,414 | $40,129,000 | 5.01% |
| Intellectus Partners, LLC | 1,091,505 | $10,795,000 | 3.84% |
| ArchPoint Investors | 617,213 | $6,104,000 | 2.49% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $563,000 | 1.85% |
| Casdin Capital, LLC | 1,650,000 | $16,319,000 | 1.07% |